LINC01493

Across TCGA pan-cancer cohorts, LINC01493 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC01493 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher LINC01493 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01493 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

PAAD, BLCA, and ESCA are the cancer types where LINC01493 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.159	0.650	<.001	72	view →
BLCA	DFS	Tertile	IV	0.598	0.188	.020	48	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
LUSC	DFS	Tertile	III,IV	0.079	0.658	<.001	36	view →
UCEC	OS	Tertile	IV	0.282	0.604	.024	36	view →
THCA	OS	Tertile	All	0.922	0.986	.005	18	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
LUAD	OS	Tertile	III,IV	0.057	0.680	<.001	18	view →
READ	DFS	Tertile	All	0.251	0.703	.007	18	view →
BRCA	DFS	Tertile	II,III,IV	0.413	0.522	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC01493–PAAD (OS)

Open the PAAD breakdown →